Xanax XR recalled after discovery that tablets may fail to release medication properly

A batch of Xanax XR is being recalled nationwide after the manufacturer found it may not release the medication in the body as intended.Viatris, Inc. initiated the voluntary recall for ALPRAZolam extended-release tablets, 3 mg, distributed in 60-count bottles under lot number 8177156 with an expiration date of Feb. 28, 2027, according to the U.S. Food and Drug Administration.Xanax XR is a benzodiazepine used to treat panic disorder and anxiety in adults.The issue was classified as a Class II recall, meaning it may cause temporary or medically reversible health effects but is unlikely to result...

4 days ago

On HALO